Issue
Alert me when new journal issues are available via or via
Editorial Board page IFC Full-Text PDF (43 KB)
Research papers
A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: A five-year follow-up, 16 October 2007 Douglas Turkington, Tom Sensky, Jan Scott, Thomas RE Barnes, Ula Nur, Ronald Siddle, Katherine Hammond, Neshika Samarasekara, David Kingdon pages 1-7 Abstract | Full Text | Full-Text PDF (160 KB)
Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia, 28 June 2007 C. Daniel Mullins, Nour A. Obeidat, Brian J. Cuffel, John Naradzay, Antony D. Loebel pages 8-15 Abstract | Full Text | Full-Text PDF (259 KB)
Regional thinning of the cerebral cortex in schizophrenia: Effects of diagnosis, age and antipsychotic medication, 16 October 2007 Ragnar Nesvåg, Glenn Lawyer, Katarina Varnäs, Anders M. Fjell, Kristine B. Walhovd, Arnoldo Frigessi, Erik G. Jönsson, Ingrid Agartz pages 16-28 Abstract | Full Text | Full-Text PDF (761 KB)
Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment, 02 November 2007 Robert K. McClure, Khary Carew, Stacy Greeter, Emily Maushauer, Grant Steen, Daniel R. Weinberger pages 29-39 Abstract | Full Text | Full-Text PDF (234 KB)
Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels, 22 November 2007 Jose de Leon, Juan Carlos Correa, Gualberto Ruaño, Andreas Windemuth, Maria J. Arranz, Francisco J. Diaz pages 40-46 Abstract | Full Text | Full-Text PDF (165 KB)
Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants, 02 November 2007 Vicki L. Ellingrod, Del D. Miller, Stephan F. Taylor, Jessica Moline, Timothy Holman, Jane Kerr pages 47-54 Abstract | Full Text | Full-Text PDF (227 KB)
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: The QUERISOLA trial, 16 October 2007 Emilio Sacchetti, Paolo Valsecchi, Giovanni Parrinello, for the QUERISOLA Group pages 55-65 Abstract | Full Text | Full-Text PDF (371 KB)
In vitro and in vivo demonstration of risperidone implants in mice, 03 September 2007 C. Rabin, Y. Liang, R.S. Ehrlichman, A. Budhian, K.L. Metzger, C. Majewski-Tiedeken, K.I. Winey, S.J. Siegel pages 66-78 Abstract | Full Text | Full-Text PDF (982 KB)
The course of tardive dystonia in Afro Caribbean patients, a population-based study: The Curacao Extrapyramidal Syndromes Study: VII, 16 October 2007 P.N. van Harten, G.E. Matroos, J. Van Os pages 79-83 Abstract | Full Text | Full-Text PDF (129 KB)
Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia, 29 October 2007 Mechteld L.C. Hoogendoorn, Jacob A.S. Vorstman, Gholam R. Jalali, Jean-Paul Selten, Richard J. Sinke, Beverly S. Emanuel, René S. Kahn pages 84-88 Abstract | Full Text | Full-Text PDF (144 KB)
Allelic association of G72/G30 with schizophrenia and bipolar disorder: A comprehensive meta-analysis, 19 November 2007 Jiajun Shi, Judith A. Badner, Elliot S. Gershon, Chunyu Liu pages 89-97 Abstract | Full Text | Full-Text PDF (235 KB) | Add-Ons
No association between the DRD3 Ser9Gly polymorphism and schizophrenia, 15 August 2007 Ferid Fathalli, Guy A. Rouleau, Lan Xiong, Karim Tabbane, Chawki Benkelfat, Rosherrie Deguzman, Danics Zoltan, Samarthji Lal, Sarogini D’cruz, Ridha Joober pages 98-104 Abstract | Full Text | Full-Text PDF (179 KB)
Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients, 25 October 2007 Cynthia Shannon Weickert, Debora A. Rothmond, Thomas M. Hyde, Joel E. Kleinman, Richard E. Straub pages 105-110 Abstract | Full Text | Full-Text PDF (596 KB)
Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: Analysis of the National Brain Databank microarray collection, 25 October 2007 Rajiv P. Sharma, Dennis R. Grayson, David P. Gavin pages 111-117 Abstract | Full Text | Full-Text PDF (249 KB)
Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei, 29 October 2007 William Byne, Stella Dracheva, Benjamin Chin, James M. Schmeidler, Kenneth L. Davis, Vahram Haroutunian pages 118-128 Abstract | Full Text | Full-Text PDF (769 KB)
Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia, 29 October 2007 Shruti N. Mitkus, Thomas M. Hyde, Radhakrishna Vakkalanka, Bhaskar Kolachana, Daniel R. Weinberger, Joel E. Kleinman, Barbara K. Lipska pages 129-138 Abstract | Full Text | Full-Text PDF (388 KB)
The schizophrenia brain exhibits low-level aneuploidy involving chromosome 1, 24 September 2007 Yuri B. Yurov, Ivan Y. Iourov, Svetlana G. Vorsanova, Irina A. Demidova, Viktor S. Kravetz, Alphia K. Beresheva, Alexei D. Kolotii, Viktor V. Monakchov, Natalia A. Uranova, Viktor M. Vostrikov, Ilia V. Soloviev, Thomas Liehr pages 139-147 Abstract | Full Text | Full-Text PDF (346 KB)
Decreased expression of reelin receptor VLDLR in peripheral lymphocytes of drug-naive schizophrenic patients, 16 October 2007 Katsuaki Suzuki, Kazuhiko Nakamura, Yasuhide Iwata, Yoshimoto Sekine, Masayoshi Kawai, Genichi Sugihara, Kenji J. Tsuchiya, Shiro Suda, Hideo Matsuzaki, Nori Takei, Kenji Hashimoto, Norio Mori pages 148-156 Abstract | Full Text | Full-Text PDF (733 KB)
Diffusion tensor imaging in schizophrenia: Relationship to symptoms, 22 November 2007 Laurie R. Skelly, Vince Calhoun, Shashwath A. Meda, Jinsuh Kim, Daniel H. Mathalon, Godfrey D. Pearlson pages 157-162 Abstract | Full Text | Full-Text PDF (513 KB)
Viral regulation of aquaporin 4, connexin 43, microcephalin and nucleolin, 12 November 2007 S. Hossein Fatemi, Timothy D. Folsom, Teri J. Reutiman, Robert W. Sidwell pages 163-177 Abstract | Full Text | Full-Text PDF (1367 KB) | Add-Ons
Newspaper reporting on schizophrenia: A content analysis of five national newspapers at two time points, 08 October 2007 Sarah Clement, Nena Foster pages 178-183 Abstract | Full Text | Full-Text PDF (151 KB)
Evaluation of the German WPA “Program against stigma and discrimination because of schizophrenia — Open the Doors”: Results from representative telephone surveys before and after three years of antistigma interventions, 25 October 2007 Wolfgang Gaebel, Harald Zäske, Anja E. Baumann, Joachim Klosterkötter, Wolfgang Maier, Petra Decker, Hans-Jürgen Möller pages 184-193 Abstract | Full Text | Full-Text PDF (230 KB)
Associations of multiple domains of self-esteem with four dimensions of stigma in schizophrenia, 29 October 2007 Paul H. Lysaker, Jack Tsai, Philip Yanos, David Roe pages 194-200 Abstract | Full Text | Full-Text PDF (160 KB)
Subjective and objective quality of life in schizophrenia, 08 October 2007 Jenille M. Narvaez, Elizabeth W. Twamley, Christine L. McKibbin, Robert K. Heaton, Thomas L. Patterson pages 201-208 Abstract | Full Text | Full-Text PDF (213 KB)
The relationship between functional capacity and community responsibilities in middle-aged and older Latinos of Mexican origin with chronic psychosis, 16 October 2007 Veronica Cardenas, Brent T. Mausbach, Concepcion Barrio, Jesus Bucardo, Dilip Jeste, Thomas Patterson pages 209-216 Abstract | Full Text | Full-Text PDF (185 KB)
What is specific to suicide in schizophrenia disorder? Demographic, clinical and behavioural dimensions, 18 October 2007 Alexander McGirr, Gustavo Turecki pages 217-224 Abstract | Full Text | Full-Text PDF (171 KB)
‘Jumping to conclusions’ and delusions in psychosis: Relationship and response to treatment, 26 September 2007 Mahesh Menon, Romina Mizrahi, Shitij Kapur pages 225-231 Abstract | Full Text | Full-Text PDF (220 KB)
Apathy and the processing of novelty in schizophrenia, 20 September 2007 Robert M. Roth, Nancy S. Koven, Jo Cara Pendergrass, Laura A. Flashman, Thomas W. McAllister, Andrew J. Saykin pages 232-238 Abstract | Full Text | Full-Text PDF (152 KB)
What aspects of emotional functioning are impaired in schizophrenia?, 03 August 2007 Ellen S. Herbener, Woojin Song, Tin T. Khine, John A. Sweeney pages 239-246 Abstract | Full Text | Full-Text PDF (278 KB)
Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits, 25 October 2007 Morris Goldman, Megan Marlow-O'Connor, Ivan Torres, C.S. Carter pages 247-255 Abstract | Full Text | Full-Text PDF (514 KB)
Dissecting the cellular contributions to early visual sensory processing deficits in schizophrenia using the VESPA evoked response, 12 November 2007 Edmund C. Lalor, Sherlyn Yeap, Richard B. Reilly, Barak A. Pearlmutter, John J. Foxe pages 256-264 Abstract | Full Text | Full-Text PDF (580 KB)
N100 and P300 amplitude to Go and No–Go variants of the auditory oddball in siblings discordant for schizophrenia, 19 November 2007 Alex Sumich, Veena Kumari, Phillipa Dodd, Ulrich Ettinger, Catherine Hughes, Elizabeth Zachariah, Tonmoy Sharma pages 265-277 Abstract | Full Text | Full-Text PDF (755 KB)
The perception of emotion-free faces in schizophrenia: A magneto-encephalography study, 29 October 2007 Juan J. López-Ibor, María-Inés López-Ibor, María-Andreína Méndez, María-Dolores Morón, Laura Ortiz-Terán, Alberto Fernandez, Marina Diaz-Marsá, Tomás Ortiz pages 278-286 Abstract | Full Text | Full-Text PDF (366 KB)
Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950–2005, 22 November 2007 Rebecca M. Capasso, Timothy W. Lineberry, J. Michael Bostwick, Paul A. Decker, Jennifer St. Sauver pages 287-294 Abstract | Full Text | Full-Text PDF (191 KB)
Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients, 08 November 2007 Anvita Kale, Sadhana Joshi, Nilesh Naphade, Swati Sapkale, M.S.V.K. Raju, Anilkumar Pillai, Henry Nasrallah, Sahebarao P. Mahadik pages 295-301 Abstract | Full Text | Full-Text PDF (304 KB)
Parental history of Type 2 diabetes in patients with nonaffective psychosis, 22 November 2007 Emilio Fernandez-Egea, Brian Miller, Miguel Bernardo, Thomas Donner, Brian Kirkpatrick pages 302-306 Abstract | Full Text | Full-Text PDF (133 KB)
Obstetrical complications in people at risk for developing schizophrenia, 26 October 2007 Jacob S. Ballon, Katherine A. Dean, Kristin S. Cadenhead pages 307-311 Abstract | Full Text | Full-Text PDF (137 KB)
ITAREPS: Information Technology Aided Relapse Prevention Programme in Schizophrenia, 08 October 2007 Filip Španiel, Pavel Vohlídka, Jan Hrdlička, Jiří Kožený, Tomáš Novák, Lucie Motlová, Jan Čermák, Josef Bednařík, Daniel Novák, Cyril Höschl pages 312-317 Abstract | Full Text | Full-Text PDF (144 KB)
Extrapolation between measures of symptom severity and change: An examination of the PANSS and CGI, 18 October 2007 Stephen Z. Levine, Jonathan Rabinowitz, Rolf Engel, Eva Etschel, Stefan Leucht pages 318-322 Abstract | Full Text | Full-Text PDF (248 KB)
Letters to the Editor
Antipsychotic polypharmacy does not increase the risk for side effects, 22 October 2007 Soma Ganesan, Ross Taylor, Ian Forbes, Kiran Rabheru, Jane Dumontet, Ric M. Procyshyn pages 323-324 Full Text | Full-Text PDF (89 KB)
Lamotrigine-associated exacerbation of positive symptoms in paranoid schizophrenia, 13 September 2007 George Konstantakopoulos, Panagiotis Oulis, Panagiota G. Michalopoulou, George C. Koulouris, Vasilios G. Masdrakis pages 325-326 Full Text | Full-Text PDF (98 KB)
Tobacco, alcohol and cannabis use in Tunisian patients with schizophrenia, 10 August 2007 Xavier Laqueille, Souheil Ghodhbane, Fethi Nacef, Zied Choubani, Mohamed Nehdi, Saïda Douki, Alain Dervaux pages 327-328 Full Text | Full-Text PDF (101 KB)
A potential novel paradigm for testing digit-color synesthetic-like experiences in schizophrenia, 30 June 2007 Anwar Sarhan, Haitham Jahrmi, Michael T. Compton pages 329-330 Full Text | Full-Text PDF (99 KB)
Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
